Dear Doctor - Participate in the Survey on breast cancer " The American Cancer Society’s most recent estimates for breast cancer in the United States are for 2018. In 2018, an estimated 266,120 new cases of invasive breast cancer will be diagnosed in women in the U.S. This includes 88060 cases of ductal carcinoma in situ (DCIS), which is a non-invasive form of breast cancer. Additionally, it is estimated that 63,960 women will die from breast cancer this year. However, death rates have been decreasing since 1989 due largely to improvements in screening and treatment advances. It is estimated that there are 3,410,000 women alive today who have been diagnosed with breast cancer at some point during their lives. Risk factors for developing breast cancer include: • being female and getting older – about two out of three invasive breast cancers are found in women who are 65 or older; • personal history of certain types of cancer – including ovarian cancer, ductal carcinoma in situ (DCIS), and lobular carcinoma in situ (LCIS); • family history of breast cancer – about 5 to 10% of invasive breast cancers are thought to be hereditary; • having dense breasts – denser breasts have more connective and glandular tissue than fatty tissue and can be more difficult to evaluate on a mammogram; • previous abnormal breast biopsy – an abnormal biopsy is one where atypical cells are found; Participate in Surveys "
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation